1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Japan Proton Therapy Outlook 2020

Japan Proton Therapy Outlook 2020

  • November 2015
  • -
  • RNCOS
  • -
  • 55 pages

In the field of cancer treatment, Japan was second among the world’s countries to offer proton therapy. However, the access to proton therapy is limited for a vast population, owing to a low number of proton therapy centers. Hence, a large number of research institutions and hospitals have started investing in proton therapy to make it more accessible to the colossal pool of cancer patients.

According to the “Japan Proton Therapy Outlook 2020” report by RNCOS, by 2020, there will be 13 operational proton therapy centers in Japan. Consequently, the market will attain revenue of around US$ 150 Million by 2020, growing at a CAGR of 13% during the forecast period of 2015-2020. The report also provides an insight into the cancer demographics of Japan and the various possible reasons for an increasing incidence of cancer patients in the country.

Based on a complex correlation-regression model accounting population demographics, disease statistics, macro & micro economic indicators of the country, and more, the report provides an account of the potential proton therapy market in Japan. The report also includes the current and future demands for the number of proton therapy centers in the country. Furthermore, analysis of the current and upcoming proton therapy centers, along with an estimation of the shortage of proton centers in the current and future scenario is also provided, which is intended to help players extract benefits from the largely untapped but lucrative proton therapy market.

The report next provides an insight into the drivers, challenges, opportunities and market trends which can have a major influence in shaping the said growing market. On the competitive front, the report covers the current stand of the market and its probable transformation by 2020. There is also a ‘strengths and weaknesses’ analysis of equipment vendors along with their business overviews, products & services, and existing & planned installations in Japan till 2020, thus making the report a must read for consultants and companies planning to enter the market.

Table Of Contents

Japan Proton Therapy Outlook 2020
1. Analyst View
2. Research Methodology
3. Japan Cancer Demographics
3.1 Incidence by Site
4. Current Radiation Therapies
4.1 Third Dimensional Conformal Therapy (CRT)
4.2 Image Guided Radiotherapy (IGRT)
4.3 Intensity Modulated Radiotherapy (IMRT)
4.4 Stereotactic Radiotherapy
4.5 Neutron Therapy
4.6 Heavy Ion Radiotherapy
4.7 Proton Therapy
4.7.1 Need for Proton Therapy
5. Components of a Standard Proton Therapy Center
5.1 Proton Accelerator
5.2 Beam Transport System
5.3 Beam Delivery System
5.4 Nozzle
5.4.1 Single Scattering
5.4.2 Double Scattering
5.4.3 Uniform Scanning Nozzle
5.4.4 Pencil Scanning Nozzle
5.5 Treatment Planning System
5.6 Image Viewers
5.7 Patient Positioning System
5.8 Human Resource
6. Japan Proton Therapy Market
6.1 Current Market Size and Future Growth
6.2 Potential Patients
6.2.1 Market Penetration
6.3 Opportunity Assessment
6.4 Existing and Forthcoming Players Analysis
6.4.1 Equipment Providers
6.5 Proton Therapy Centers Analysis
7. Market Dynamics
7.1 Drivers
7.1.1 Increasing Incidence of Cancer
7.1.2 Benefits of Proton Therapy over Conventional Therapies
7.1.3 Low Cost of Treatment
7.1.4 High Disposable Income
7.2 Challenges
7.2.1 Increasing Adoption of Carbon Ion Radiotherapy
7.2.2 Reimbursement Issues
7.3 Opportunity
7.3.1 Medical Tourism
8. Market Trends
8.1 Centers with Lesser Number of Treatment Rooms
8.2 Dominance of Domestic Players in Proton Therapy Market
9. Competitive Landscape and Strategic Analysis
9.1 Hitachi Medical Corporation (A Subsidiary of Hitachi Ltd.)
9.2 Sumitomo Heavy Industries, Ltd.
9.3 Mitsubishi Electric Corporation

List of Figures:

Figure 4-1: Advantages of Proton Therapy over Conventional Radiation Therapy
Figure 5-1: Components of a Proton Therapy Center
Figure 6-1: Proton Therapy Market (Million US$), 2014-2020
Figure 6-2: Share of Proton Therapy Market in Potential Market (%), 2015
Figure 6-3: Share of Proton Therapy Market in Potential Market (%), 2020
Figure 6-4: Demand of Proton Therapy Centers (2015 and 2020)
Figure 6-5: Shortage of Proton Therapy Centers (2015 and 2020)
Figure 6-6: Share of Vendors by Number of Proton Accelerators Installed (%), 2015
Figure 6-7: Share of Vendors by Number of Proton Accelerators Installed (%), 2020
Figure 6-8: Number of Patients Treated with Proton Therapy for Cancer Type (%), 2013
Figure 7-1: Cancer Incidence ('000), 2012 to 2035
Figure 8-1: Proton Therapy Center by Number of Treatment Rooms (2015 and 2020)

List of Tables:

Table 3-1: Cancer Incidence Growth by Site (2015-2035)
Table 5-1: Human Resource Requirements and their Role in Proton Therapy Center
Table 6-1: Potential Patients for Proton Therapy (2015 and 2020)
Table 6-2: Proton Therapy Centers, (2015)
Table 6-3: Upcoming Proton Therapy Centers (2015 - 2020)
Table 6-4: Proton Therapy Equipment Providers with Number of Installations, (2015)
Table 6-5: Proton Therapy Equipment Providers with Number of Installations by 2020
Table 9-1: Hitachi - Key Financials (Millions US$), 2013-2015
Table 9-2: Hitachi - Proton Therapy Installations in Japan
Table 9-3: Hitachi - Upcoming Proton Therapy Installations in Japan
Table 9-4: Hitachi - Strengths and Weaknesses
Table 9-5: Sumitomo - Key Financials (Million US$), 2013-2015
Table 9-6: Sumitomo - Proton Therapy Installations in Japan
Table 9-7: Sumitomo - Upcoming Proton Therapy Installations in Japan
Table 9-8: Sumitomo - Strengths and Weaknesses
Table 9-9: Mitsubishi - Key Financials (Million US$), 2013-2015
Table 9-10: Mitsubishi - Proton Therapy Installations in Japan
Table 9-11: Mitsubishi - Upcoming Proton Therapy Installations in Japan
Table 9-12: Mitsubishi - Strengths and Weaknesses

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Atrial Fibrillation - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Atrial Fibrillation - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • August 2016
  • by Global Data

PharmaPoint: Atrial Fibrillation - Global Drug Forecast and Market Analysis to 2025 Summary Atrial fibrillation (AF) is the most common cardiac arrhythmia and is a heart condition that causes an irregula ...

PharmaPoint: Venous Thromboembolism - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Venous Thromboembolism - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • August 2016
  • by Global Data

PharmaPoint: Venous Thromboembolism - Global Drug Forecast and Market Analysis to 2025 Summary Venous thromboembolism (VTE) is a disease that includes a myriad of life-threatening disorders ranging from ...

PharmaPoint: Acute Coronary Syndrome - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Acute Coronary Syndrome - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • August 2016
  • by Global Data

PharmaPoint: Acute Coronary Syndrome - Global Drug Forecast and Market Analysis to 2025 Summary Cardiovascular diseases (CVD), including ischemic heart disease and stroke, are the leading causes of mortality ...

Ulcerative Colitis: Kol Insight

September 2016 $ 8085

Hepatitis C: Kol Insight

September 2016 $ 8085

Download Unlimited Documents from Trusted Public Sources

Therapy Market in Europe

  • November 2016
    19 pages
  • Therapy  

  • Europe  

View report >

Therapy Market and Hypertension Statistics in Asia and the US

  • November 2016
    26 pages
  • Therapy  

    Hypertension  

    Cardiovascular ...  

  • Asia  

    United States  

    Europe  

View report >

Therapy Market in the US - Forecast

  • November 2016
    6 pages
  • Therapy  

    Opioid  

  • United States  

View report >

Related Market Segments :

Therapy

ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.